logo

Last Update

This profile was last updated on 7/8/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Mitch Dowsett?

Mitch Dowsett

Professor

The Royal Marsden NHS Foundation Trust

HQ Phone:  +44 20 8661 3400

Email: m***@***.uk

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

The Royal Marsden NHS Foundation Trust

Downs Road

Sutton, Greater London,SM2 5PT

United Kingdom

Company Description

The Royal Marsden opened its doors in 1851 as the world's first hospital dedicated to cancer diagnosis, treatment, research and education. Today, together with its academic partner, The Institute of Cancer Research (ICR), it is the largest and most comprehen...more

Background Information

Employment History

Head of the Academic Department of Biochemistry and Head of the Centre for Molecular Pathology

Royal Marsden Hospital


Professor of Biochemical Endocrinology

Institute of Cancer Research


Affiliations

Radius Health, Inc.

Oncology Advisory Board Member


Immunovia AB

Advisory Board Member


Executive and/or Steering Committees

Committees


ASCO/CAP

International Member of the Steering Committee


Breast International Group

Member of the Executive Board


ATAC

Member of the Steering and Executive Committees of Several Prominent International Breast Cancer Trials


American Society of Clinical Oncology

Member of the Special Awards Committee


HERA Trial

Member of the Executive Committee


Aromatase Inhibitor Overview Group

Planning Committee


Wales Cancer Bank

Advisory Board Member


NTRAC Translational

Chairman of the Research Committee


Steering Committee

Member


NanoString Technologies Inc

Member


Breast International Group

Executive Committee


Education

BSc

Imperial College


PhD

Chester Beatty Cancer Research Institute at London University


PhD

Institute of Cancer Research


Web References(176 Total References)


Staff at The Breast Unit | The Royal Marsden NHS Foundation Trust

www.royalmarsden.nhs.uk [cached]

Professor Mitch Dowsett, Translational Research


Advisory Board - Immunovia

immunovia.com [cached]

Prof. Mitch Dowsett
Head of the Academic Department of Biochemistry and Head of Breast Cancer Translational Research, Royal Marsden Hospital and Institute of Cancer Research, London, England


Professor Mitch Dowsett | The Royal Marsden BRC

www.cancerbrc.org [cached]

Professor Mitch Dowsett
Professor Mitch Dowsett Professor Mitch Dowsett is Head of the Centre for Molecular Pathology, Head of the Ralph Lauren Centre for Breast Cancer Research and Head of the joint Academic Department of Biochemistry at The Royal Marsden and The Institute of Cancer Research. He also holds the posts of Professor of Biochemical Endocrinology at The Royal Marsden, and Professor of Translational Research at the Breast Cancer Now Research Centre at the ICR. Professor Dowsett is the theme lead for Molecular Pathology for the NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research and leader of the Endocrinology Team in the Breakthrough Breast Cancer Research Centre. He was awarded the William McGuire Memorial Lectureship in 2007 and has been a Senior Investigator of the NIHR since 2009. He recently became only the third recipient from the UK of the Brinker Award for Scientific Distinction in Clinical Research. Professor Dowsett's research focuses almost exclusively on breast cancer and predominantly on hormonal aspects of the disease and biomarkers of response. He has been closely involved with the clinical development of aromatase inhibitors and the establishment of Ki67 as an intermediate marker of treatment benefit. His work has focused mainly on the assessment of biomarkers in large Phase III clinical trials. He has written widely on this, including on the general potential and limitation of such studies.


Our research leaders | The Royal Marsden BRC

www.cancerbrc.org [cached]

Professor Mitch Dowsett
Breast cancer: Professor Mitch Dowsett


Endocrinology | Breakthrough Breast Cancer research

www.breakthroughresearch.org.uk [cached]

The newly founded Endocrinology Team, which was developed by the joining of the Translational Research Team (Mitch Dowsett) and the Molecular Endocrinology Team (Mitch Dowsett & Lesley-Ann Martin) to form a concerted effort, to generate increased knowledge on the important mechanisms of response and resistance specifically to oestrogen deprivation and most particularly to AIs by making use of large clinical data sets and in vitro laboratory models for hypothesis driven study.
Professor Mitch Dowsett Professor Mitch Dowsett Professor Mitch Dowsett received his Ph.D. from Chester Beatty Cancer Research Institute at London University. He is currently Head of the Academic Department of Biochemistry at the Royal Marsden Hospital, Professor of Biochemical Endocrinology at the Institute of Cancer Research, and Professor of Translational Research in the Breakthrough Breast Cancer Centre, London. Professor Dowsett's research focuses almost exclusively on breast cancer and predominantly on hormonal aspects of the disease and biomarkers of response. He has been closely involved with the clinical development of aromatase inhibitors and the establishment of Ki67 as an intermediate marker of treatment benefit. His work has focused mainly on the assessment of biomarkers in large phase III clinical trials. He has written widely on this, including on the general potential and limitation of such studies. Professor Dowsett has authored over 500 published papers related to breast cancer, and was the 2007 William L McGuire Memorial Lecturer. He is a member of the Executive Board of the Breast International Group (BIG), and sits on the Executive/Steering Committees of several clinical trials. He chairs the translational research committees for the ATAC and HERA clinical trials and is co-PI of the national POETIC trial of preoperative endocrine therapy. He is the founding chairman of the NCRI Biomarker and Imaging Clinical Study Group and is a member of the NCRI Breast Cancer Study Group. He was an author of both the UK and the ASCO/CAP guidelines for HER2 diagnostics. He is the international member of the ASCO/CAP Steering Committee for ER/PgR IHC guidelines. Professor Mitch Dowsett


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory